Taiwan FDA registration 1107e486ed51792ab218d88f28dbcdeb
Nipro mimics blood glucose solution (unsterilized)
TW: 尼普洛類比血糖品管液(未滅菌)
Taiwan·Risk Class 1·NIPRO DIAGNOSTICS, INC.·Registered Dec 24, 2010 – Dec 24, 2020CancelledRegistration details
- Analysis ID
- 1107e486ed51792ab218d88f28dbcdeb
- Customs Code
- DHA04400974000
Company information
- Manufacturer
- NIPRO DIAGNOSTICS, INC.
- Manufacturer Country
- United States
- Authorized Representative
- Taiwan Nipro Medical Device Co., Ltd
Product details
- Intended Use
- Limited to the first level identification range of quality control materials (analytical and non-analytical) (A.1660) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- import
Dates and status
- Registration Date
- Dec 24, 2010
- Expiry Date
- Dec 24, 2020
- Cancellation Date
- May 19, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Nipro mimics blood glucose solution (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 1107e486ed51792ab218d88f28dbcdeb and manufactured by NIPRO DIAGNOSTICS, INC.. The authorized representative in Taiwan is Taiwan Nipro Medical Device Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices